Processing

Please wait...

Settings

Settings

Goto Application

1. WO2008037416 - USE OF THEOGALLIN FOR THE TREATMENT OF MENTAL CONCENTRATION DISORDERS, DEPRESSION AND DEMENTIA

Publication Number WO/2008/037416
Publication Date 03.04.2008
International Application No. PCT/EP2007/008308
International Filing Date 25.09.2007
IPC
A61K 31/222 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
222with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61P 25/24 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
24Antidepressants
A61P 25/28 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
25Drugs for disorders of the nervous system
28for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
CPC
A61K 31/222
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
22of acyclic acids, e.g. pravastatin
222with compounds having aromatic groups, e.g. dipivefrine, ibopamine
A61K 31/235
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
21Esters, e.g. nitroglycerine, selenocyanates
215of carboxylic acids
235having an aromatic ring attached to a carboxyl group
Applicants
  • PLANTEXTRAKT GMBH & CO. KG [DE]/[DE] (AllExceptUS)
  • KLER, Adolf [DE]/[DE] (UsOnly)
  • ZENGER, Reinhold [DE]/[DE] (UsOnly)
  • DIMPFEL, Wilfried [DE]/[DE] (UsOnly)
Inventors
  • KLER, Adolf
  • ZENGER, Reinhold
  • DIMPFEL, Wilfried
Agents
  • HÜBNER, Gerd
Priority Data
10 2006 045 764.126.09.2006DE
Publication Language German (DE)
Filing Language German (DE)
Designated States
Title
(DE) VERWENDUNG VON THEOGALLIN ZUR BEHANDLUNG VON MENTALEN KONZENTRATIONSLEISTUNGSSTÖRUNGEN, DREPRESSION UND DEMENZ
(EN) USE OF THEOGALLIN FOR THE TREATMENT OF MENTAL CONCENTRATION DISORDERS, DEPRESSION AND DEMENTIA
(FR) UTILISATION DE THÉOGALLINE DANS LA PRODUCTION D'UN MÉDICAMENT DESTINÉ À ÊTRE UTILISÉ DANS LA PROPHYLAXIE OU LE TRAITEMENT DE MALADIES NEUROLOGIQUES ET PSYCHIATRIQUES DU SYSTÈME NERVEUX CENTRAL, EN PARTICULIER DE TROUBLES DE LA CONCENTRATION MENTALE, LA DÉPRESSION ET LA DÉMENCE
Abstract
(DE)
Theogallin, seine Derivate, sein Metabolit Chinasäure, von Derivaten davon, seiner Metaboliten oder die pharmazeutisch annehmbaren Salze dieser Stoffe sind zur Herstellung eines Arzneimittels zur Prophylaxe bzw. Behandlung von neurologischen und psychiatrischen Erkrankungen des zentralen Nervensystems, insbesondere von Demenzen, wie Morbus Alzheimer oder Morbus Parkinson, von Depressionen und Konzentrationsleistungsstörungen, wie beim Aufmerksamkeitsdefizits-Hyperaktivitätssyndrom verwendbar.
(EN)
Theogallin, its derivatives, its metabolite quinic acid, the derivatives thereof, its metabolites or the pharmaceutically acceptable salts of said substances can be used for producing a drug for use in the prophylaxis or treatment of neurological and psychiatric diseases of the central nervous system, especially of dementia such as Alzheimer's disease or Parkinson's disease, of depressions and concentration disorders such as attention deficit hyperactivity disorder.
(FR)
L'invention concerne la théogalline, ses dérivés, son acide quinique des métabolites, leurs dérivés, ses métabolites ou les sels pharmaceutiquement acceptables desdites substances pouvant être utilisés dans la production de médicaments utilisés dans la prophylaxie ou le traitement de maladies neurologiques ou psychiatriques du système nerveux central, en particulier la démence, telle que la maladie d'Alzheimer ou la maladie de Parkinson, les dépressions et les troubles de la concentration tels que l'hyperactivité avec déficit de l'attention.
Also published as
Latest bibliographic data on file with the International Bureau